Irvine, CA, United States
Irvine, CA, United States

Allergan, Inc., is an American worldwide pharmaceutical company, focusing on ophthalmic pharmaceuticals, dermatology, neuroscience, urology and cosmetics. Wikipedia.


Time filter

Source Type

Patent
Allergan, Inc. | Date: 2017-01-23

A headache can be treated more effectively by co-administration of a botulinum toxin and a triptan drug to a patient and/or the effectiveness of a triptan medication can be increased. The botulinum toxin can be botulinum toxin type A and the botulinum toxin can be administered to or to the vicinity of where a patient experiences or is predisposed to experience pain or a headache.


The present invention relates to novel amide derivatives of N-urea substituted amino acids, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals as modulators of the N-formyl peptide receptor like-1 (FPRL-1) receptor.


Patent
Allergan, Inc. | Date: 2017-01-04

The present disclosure relates to antibodies and polynucleotides encoding the same, which may be used to prevent, control, or reduce the activity of the complement pathway. In addition, the disclosure is directed to compositions and methods for diagnosing and treating diseases mediated by or involving complement Factor Bb. Specifically, the disclosure is related to anti-complement Factor Bb antibodies.


Patent
Allergan, Inc. | Date: 2017-04-19

The present invention provides stabilized cream formulations of oxymetazoline and uses thereof. The present invention also provides a method of treating facial erythema associated with rosacea in a patient in need of such treatment, comprising topically administering once or twice daily to the site of erythema on the face of the patient a pharmaceutical composition comprising 0.5%, 1.0% or 1.5% oxymetazoline or a pharmaceutically acceptable salt thereof as the sole active ingredient.


Patent
Allergan, Inc. | Date: 2017-01-30

Provided are injectable, hyaluronic acid-based hydrogel compositions including conjugated vitamins.


The present invention provides a compound, that is a 1-({halo-2-[(2-hydrocarbyl or substituted hydrocarbyl)oxy]phenyl}methyl)-(fused bicyclic nitrogen heteroaryl) carboxylic acid or an ester or sulfonamide thereof. The compound may be represented by the following formula Wherein R_(1), R_(2), R_(3), R_(4 )A, X, W, Z and Y are as defined in the specification. The compounds may be administered to treat DP, FP, EP1, TP and/or EP4 receptor-mediated diseases or conditions.


Patent
Allergan, Inc. | Date: 2017-02-06

Disclosed herein are compounds having formula (I) wherein a dashed line represents the presence or absence of a bond; Y is an organic acid functional group, or an amide or ester thereof; or Y is hydroxymethyl or an ester thereof; or Y is a tetrazolyl functional group; A is (CH_(2))_(6), cis-CH_(2)CHCH(CH_(2))_(3), or CH_(2)CC(CH_(2))_(3), wherein 1 or 2 carbon atoms may be replaced by S or O; or A is (CH_(2))_(m)Ar(CH_(2))_(o), wherein Ar is interarylene or heterointerarylene, the sum of m and o is 1, 2, 3, or 4, and wherein 1 CH_(2) may be replaced by S or O, and 1 CH_(2)CH_(2) may be replaced by CHCH or CC; U^(1 )and U^(2 )are independently selected from H, O, OH, F, Cl, and CN; and B is aryl or heteroaryl, for use as acular hypotensive agent.


Patent
Allergan, Inc. | Date: 2017-02-06

Disclosed herein are therapeutic methods, compositions, and medicaments related to cyclosporine.


The present disclosure relates to suspension formulations and systems for the treatment of ocular conditions. The suspension formulations can include cyclosporin A and in some embodiments, Form 1 or Form 2 cyclosporin A. A delivery system can be provided that includes two parts, a first part containing particles of cyclosporin and a second part containing other components that can be combined with the first part to make a suspension formulation. The suspension can be injected into the subconjunctival or other periocular space to treat ocular conditions, such as dry eye disease.


Patent
Allergan, Inc. | Date: 2017-07-19

Methods for alleviating symptoms of osteoarthritis by local administration of a clostridial derivative, such as a botulinum toxin, are disclosed. In a peferred embodiment, onabotulinumtoxin A or BOTOX is administrered to aleviate osteoarthritis knee pain.

Loading Allergan, Inc. collaborators
Loading Allergan, Inc. collaborators